UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035489
Receipt number R000040433
Scientific Title Effectiveness of near-infrared spectroscopy neurofeedback for psychiatric disorders
Date of disclosure of the study information 2019/01/10
Last modified on 2020/12/23 17:33:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of near-infrared spectroscopy neurofeedback for psychiatric disorders

Acronym

Effectiveness of NIRS-based neurofeedback

Scientific Title

Effectiveness of near-infrared spectroscopy neurofeedback for psychiatric disorders

Scientific Title:Acronym

Effectiveness of NIRS-based neurofeedback

Region

Japan


Condition

Condition

Major depression, Bipolar disorder, Anxiety disorder, Autism spectrum disorder, Attention-deficit/hyperactivity disorder, and Healthy control

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The therapeutic effect of antidepressants for depression is reported to be about 30% in remission rate. Other treatments include electroconvulsive therapy (ECT), recurrent transcranial magnetic stimulation (rTMS), deep brain stimulation (DBS) but they have disadvantages of high invasiveness.

Neurofeedback (NFB) is an emergent approach that has been adopted in recent years as a potential intervention for a number of psychiatric disorders. In the NFB study using fMRI, it has been reported that clinical symptoms of mental disorders may be improved by repeating the training to change the neural activity of a specific brain region associated with disease.

In recent years, NFB research using NIRS has also been observed (Kinoshita et al., 2016). As a mechanism of NIRS-based NFB, we aim to improve the neural network impairments that connect the frontal lobe, limbic system, and the basal ganglia directly by continuing training to selectively activate an region of the frontal lobe.

In this study, we aim to establish the usefulness of NFB training by NIRS for psychiatric disorders.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1 Clinical evaluation scale
HAM-D, HAM-A, MADRAS, etc.

2 Neuropsychological examination
TMT, BADS, CAT, CANTAB, etc.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

We conduct a maximum of 20 NFB at a pace of 2-5 days per week.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1 Patient group
People who were diagnosed with major depression, bipolar disorder, anxiety disorder, ASD, ADHD in DSM-5

2 Healthy control group
A healthy person without a history of mental illness

Key exclusion criteria

People who satisfies one of the following

1 Combined circulatory organ, liver, kidney, respiratory organs, blood, endocrine, central nervous system diseases, and person who was judged to be extremely unstable
2 Person who has history of head trauma or substance dependence
3 People with a history of epilepsy or generalized convulsions
4 For healthy control subjects, those who are diagnosed with developmental disorder

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Bun
Middle name
Last name Yamagata

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

35 Shinanomachi Shinjuku-Ku, Tokyo

TEL

03-5363-3971

Email

yamagata@a6.keio.jp


Public contact

Name of contact person

1st name Bun
Middle name
Last name Yamagata

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

35 Shinanomachi Shinjuku-Ku, Tokyo

TEL

03-5363-3971

Homepage URL


Email

yamagata@a6.keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University

Address

35 Shinanomachi Shinjuku-Ku, Tokyo

Tel

03-5363-3503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 01 Month 08 Day

Date of IRB

2019 Year 01 Month 20 Day

Anticipated trial start date

2019 Year 01 Month 22 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 08 Day

Last modified on

2020 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040433


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name